Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LTG-001 for Acute Pain After an Abdominoplasty
NCT07102459Phase 2Completed
- Sponsor
- Latigo Biotherapeutics
- Start
- Jul 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LTG-001 in acute pain, postoperative pain, sponsored by Latigo Biotherapeutics. Started Jul 2025; status: completed.
02
Drugs
LTG-001
03
Conditions
acute painpostoperative pain
Beyond the preview
Go deeper on NCT07102459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07102459.